Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ABC handbook

This article was originally published in The Tan Sheet

Executive Summary

The American Botanical Council's newly published quality control manual for supplement firms covers the macroscopic identification of more than 150 species of botanicals used in commercial herbal products in North America, according to ABC. "The Identification of Medicinal Plants: A Handbook of the Morphology of Botanicals in Commerce" by Wendy Applequist, PhD, a botanist and assistant curator at the Missouri Botanical Garden, aims to provide "widespread access to the information required for the accurate identification of medicinal herbs," the group says in a release. Features of the handbook include 113 botanical entries, 87 detailed drawings, "some practical advice on identification" and an introduction to botanical nomenclature. The book begins shipping this month and retails to non-members for $89.95...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel